-
Friday, 04/27/2018
2 IAMR Group Research Projects have been awarded by SEPAR in the 2017 Call for Grant Applications
The SEPAR 2017 Grants of Fundació Respira (Spanish Lung Foundation) will invest around 600.000 euros in research
The IAMR research team has been successful in the 2017 call for the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) - Fundació Respira grants (http://www.separ.es). Miquel Ferrer and Enric Barbeta obtained funding to carry out their research projects in the field of respiratory diseases.
Dr. Miquel Ferrer obtained a SEPAR 2017 grant for his project Reducing the duration of antibiotic treatment of community-acquired pneumonia with high risk class and initially appropriate response. A randomised clinical trial. The aims for this trial are: 1) To assess the efficacy of 5-day antibiotic treatment compared to the usual duration of more than 7 days, in a non-inferiority design, in terms of “mortality, hospital readmission or reinitiating of antibiotic treatment at 30 days”, in a cohort of patients with community-acquired pneumonia with a PSI risk class IV-V who present an initially adequate response to treatment (clinical stability within the first 4 days of treatment alter admission); 2) To assess the efficacy of 5-day antibiotic treatment compared to the usual duration of more than 7 days on hospital lenght of stay and antibiotic-free days at 30 days and; 3) To investigate the occurrence of adverse events related to the use of study antibiotics
Enric Barbeta obtained a SEPAR 2017 grant for his project Driving Pressure and Inflammatation in Acute Respiratory Distress Syndrome. The aim of this project is to analyze the association between driving pressure and pulmonary and systemic inflammation as well as the severity of multiorgan failure in patients with ARDS undergoing invasive mechanical ventilation.
SEPAR-Fundació Respira awards a number of grants each year with the aim of encouraging research in the field of respiratory disease.
-
Tuesday, 03/20/2018
Roberto Cabrera joins the IAMR research group
He will collaborate with the Traslational Research Laboratory and Animal Model line
Doctor from the University of Barcelona with Cum Laude (2008) and graduated in Microbiology at the University of Havana in 1997. He has joined the research group in December 2017 to support the research projects related to the Traslational Research Laboratory and Animal Model line. Related with his background he will also identify the mechanisms of resistance of clinical strains.
-
Tuesday, 12/12/2017
A new combination of antibiotics allows treating 60% of hospital-acquired pneumonia
A study published in the journal The Lancet Infectious Diseases shows the ability of a new antibiotic (ceftazimida-avibactam) to treat hospital-acquired pneumonia, including ventilation-associated pneumonia. It has similar efficacy to one of the most used type of antibiotics in the treatment of this infection, carbapenems, but has the advantage of overcoming problems derived from its administration, such as the resistance of certain bacteria. Dr. Antoni Torres, Head of the Respiratory Intensive Surveillance Unit (UVIR) of the Hospital Clínic and head of the IDIBAPS team on Applied research in infectious respiratory diseases, is the principal investigator of the study and first author of the article.
-
Wednesday, 11/08/2017
A blood test allows the identification of patients with pneumonia with a higher associated mortality
The work has been published by the journal EBioMedicine.
A multidisciplinary team of researchers, led by the Hospital Clínic de Barcelona-IDIBAPS, the La Fe Hospital in Valencia and the Valladolid University Clinic Hospital, has identified an immunological subtype of Pneumonia Acquired in the Community (CAP) that is associated to a greater mortality. It is a community pneumonia with low blood lymphocytes and has twice the risk of mortality. Patients with this subtype are easy to identify using a simple hemogram, the most common blood test available in all hospitals. The work has been published by the journal EBioMedicine.
-
Friday, 10/20/2017
CHEST 2017 Murray Kornfeld Memorial Founders lecture
Prof. Antoni Torres, research Group leader of Applied research in Respiratory diseases, has been recognized as recipient of the prestigious CHEST 2017 Murray Kornfeld Memorial Founders lecture. CHEST 2017 will be held in Toronto, Ontario, Canada, October 28-November 1, 2017. There, Prof. Torres will give a lecture entitled: “Barcelona Respiratory Research Group: Trying to Change Clinical Practice”, a summary of the most relevant research findings that have changed clinical practice worldwide. Prof. Torres will be recognized and given his award at his lecture on Wednesday, November 1 at 11:00 am at the Convention Center.
-
Sunday, 10/15/2017
Denise Battaglini joins the Research Team
During her fellowship she will focus on experimental studies concerning animal models of pulmonary infection
Doctor from the University of Genova (IT) and graduated in Medicine at the University of Genova (IT) in 2013 with Laude. She is resident physician in Anesthesiology and Intensive Care in Genoa University. She joined the research group in October 2017 to perform a Research Fellowship for one year taking part of the Animal Model line.
-
Friday, 09/15/2017
Andrea Meli joins the Research Team
During his fellowship he will focus on experimental studies concerning animal models of pulmonary infection
The latest incorporation at the research group is Andrea Meli, who holds a Degree in Medicine at the University of Florence (2014). Currently, he is resident in Anesthesia and Intensive care at the University of Milan. His role in our group will be focused on experimental studies concerning animal models of pulmonary infection. -
Sunday, 09/10/2017
Dr. Arturo Huerta receives the University of Barcelona Extraordinary Doctorate Prize
His doctoral thesis focused on inflammatory response in patients with CAP and COPD
Dr. Arturo Huerta has been awarded with the University of Barcelona (UB) Extraordinary Doctorate Prize for the academic year 2016, for his thesis entitled: “Systemic inflammatory response in patients with Community Acquired Pneumonia (CAP) and Chronic Obstructive Pulmonary Disease (COPD) and in Acute Exacerbations of COPD and new other uncommon triggers”, directed by Prof. Torres and Dr. Soler. This award recognizes the quality of some of the theses defended and approved at the UB which have obtained the Excellent Cum Laude qualification. A panel designated by the Doctoral Committee of the Faculty of Medicine is responsible for assessing the candidate theses. -
Friday, 06/23/2017
European Respiratory Society (ERS) fellowship 2017 to Ana Motos
The candidate was granted for a 6 month period at Hartford Hospital group leaded by Dr. David Nicolau
Ana Motos, MSc was the winner of the ERS long-term fellowship 2017 for a 6-month stay at The Center for Anti-infective research and development located in Hartford, USA. She will be under the supervision of Dr. David Nicolau, director of this centre, to work on the project "The effects of aerosolized amikacin in pigs with severe Pseudomonas aeruginosa pneumonia".
-
Saturday, 10/01/2016
Francesco Pagliara joins the research group
During his stay he will focus on the animal research line
One of the latest incorporation at the research group is Francesco Pagliara, who holds a Degree in Medicine at the University of Perugia. At the moment he is attending the specialization in Anesthesia and Intensive care at the University of Genova. His role in our group will consist of collaborating in the animal experimentation research line.
